Hims & Hers Health is expanding its telehealth services by entering the peptide market through compounded formulations. During a recent earnings presentation, CEO Andrew Dudum revealed the company's strategic initiative to develop and distribute custom-compounded peptides to its growing customer base. This move positions Hims & Hers to capitalize on the increasing demand for peptide therapies in functional medicine and wellness sectors.

Summary auto-generated by AI from the original publisher's content. Editorial standards.